CVS健康

最新新闻

• TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David
  SEC · 2026/4/3
• CVS Bay Area Inc Cuts 1H Parent Pretax View to Y5.00M
  Dow Jones · 2026/10/8
• 公司公告
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Khichi Samrat S.
  SEC · 2026/4/3
• CVS Bay Area Inc Cuts FY Parent Pretax View to Y129.00M
  Dow Jones · 2026/10/8
• 公司公告
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.
  SEC · 2026/5/16
• RBC Capital Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $113
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Evercore Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $125
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $106
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Jefferies Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• CVS Bay Area Inc Sees 1H Parent Pretax Y81.00M
  Dow Jones · 2026/10/8
• 评级变动
  BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• 评级变动
  Jefferies Maintains CVS GROUP PLC(CVSGF.US) With Hold Rating, Raises Target Price to $18.55
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 公司公告
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.
  SEC · 2026/5/16
• 评级变动
  Barclays Maintains CVS GROUP PLC(CVSGF.US) With Buy Rating, Cuts Target Price to $21.16
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  UBS Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $118
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 公司公告
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Balser Jeffrey R.
  SEC · 2026/5/16
• 评级变动
  BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $112
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $113
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• 评级变动
  Morgan Stanley Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $111
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• Argus Research Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $114
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  A Quick Look at Today's Ratings for CVS Health(CVS.US), With a Forecast Between $107 to $126
  \u5e02\u573a\u8d44\u8baf · 2026/8/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。